Enhancing slow wave sleep with sodium oxybate to reduce the behavioral and physiological impact of sleep loss
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2008
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 29 Sep 2008 Actual end date changed from 1 May 2008 to 1 May 2008 as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Aug 2007 New trial record.